Riverside Research Information
Rising to Tackle Problems
We continuously strive to make things better by delivering high quality medicines to patients in the MENA
A specialized biosimilar service
The merger with Biosimilars Excellence enables RRI to provide high value services in biosimilars and pipeline enhancement
Market Entry Strategy
Penetrance to North American and GCC Market: the one-stop global full service solution for pharma & biotech companies
Technology-enabled services
Combining expert knowledge and new technologies to deliver market leading solutions
Diagnostic Medical Devices
The race starts here – RRI outlines its key services which will enable you to develop and commercialize medical devices
Riverside Research focuses on healthcare and wellness in the Middle East and North Africa region supported by best-in-class logistic, marketing and digital capabilities.
We are a fast-growing pharmaceutical company that distributes biosimilars, vaccines and value-added medicines in the GCC and MENA regions, helping to improve access for patients to vital pharmaceutical care at the point of need.
Riverside Research portfolio spans across critical therapeutic fields such as oncology, cardiology, neurology, psychiatry, diabetes, pain management and gastroenterology.
Riverside Research focuses on healthcare and wellness in the Middle East and North Africa region supported by best-in-class logistic, marketing and digital capabilities.
Riverside Research portfolio spans across critical therapeutic fields such as oncology, cardiology, neurology, psychiatry, diabetes, pain management and gastroenterology. The Riverside Research Group now has large pharmaceutical and solution partners in 21 countries and more than 130 satisfied clients worldwide.
Proudly worked previously with
